Harvey Rubin of the School of Medicine and the Institute for Strategic Threat Analysis and Response is cited for launching a project to help keep lifesaving vaccines cool in order to stay effective.
PHILADELPHIA – National Institutes of Health (NIH) Director Francis Collins, MD, PhD, will join Penn scientists and physicians in celebrating the opening of the new Translational Research Center (TRC) Tuesday. The TRC is the first medical research building on the Penn campus - and one of the first anywhere - to be physically integrated into facilities for patient care, namely the Perelman Center for Advanced Medicine and the Roberts Proton Therapy Center. Dr.
Penn Study: Black Cardiac Arrest Patients More Apt to Be Admitted to Hospitals With Lowest Survival Rates
PHILADELPHIA – Black cardiac arrest victims are more likely to die when they’re treated in hospitals that care for a large black population than when they’re brought to hospitals with a greater proportion of white patients, according to new research from the University of Pennsylvania School of Medicine. The study is published in the April issue of the American Heart Journal.
A Company’s Two Drugs – at Way Different Price Points – Tied in a Study on Treating Macular Degeneration
Maureen Maguire of the School of Medicine helps lead a national study comparing two macular-degeneration drugs.
National Trial Shows Equal Efficacy of Two Medications Used to Treat Age-Related Macular Degeneration
Age-related macular degeneration (AMD), a disease that damages the retina and can destroy central vision, affects approximately 1.6 million Americans. For the past five years, there has been active debate over treatment options for AMD patients because ophthalmologists have not had accurate data regarding the true efficacy of the most commonly used medication.
Donald LaVan of the School of Medicine is interviewed about changing diets in order to reduce high blood pressure.
Arthur Caplan of the School of Medicine discusses transplant centers’ right to turn away patients.
Studies of Mutated Protein in Lou Gehrig’s Disease Reveal Paths for Drug Discovery, Penn Study Suggests
Several genes have been linked to ALS, with one of the most recent called FUS. Two new studies in PLoS Biology, one from the University of Pennsylvania School of Medicine, and the other from colleagues at Brandeis University, both examined FUS biology in yeast and found that defects in RNA biology may be central to how FUS contributes to ALS, or Lou Gehrig’s disease. These findings point to new targets for developing drugs.
PHILADELPHIA -- The University of Pennsylvania School of Nursing and the School of Nursing at Peking University in Beijing have established a memorandum of understanding creating a formal research relationship between the schools. Peking University’s School of Nursing, with Guifang Guo as dean, is widely considered the premier nursing school in China.
Penn Nursing also has academic partnerships in Botswana and India.